Price
CHART BY
Frequently asked questions
What is Ironwood Pharms's market capitalization?
The market capitalization of Ironwood Pharms is $569.38M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Ironwood Pharms's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Ironwood Pharms is 22.67. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Ironwood Pharms?
Ironwood Pharms's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.154. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Ironwood Pharms's stock?
Currently, 4 analysts cover Ironwood Pharms's stock, with a consensus target price of $2.50. Analyst ratings provide insights into the stock's expected performance.
What is Ironwood Pharms's revenue over the trailing twelve months?
Over the trailing twelve months, Ironwood Pharms reported a revenue of $338.99M.
What is the EBITDA for Ironwood Pharms?
Ironwood Pharms's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $147.40M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Ironwood Pharms?
Ironwood Pharms has a free cash flow of $67.65M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Ironwood Pharms have, and what sector and industry does it belong to?
Ironwood Pharms employs approximately 253 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Ironwood Pharms's shares?
The free float of Ironwood Pharms is 156.68M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $569.38M
- EPS (TTM)
- $0.154
- Free Float
- 156.68M
- P/E ratio (TTM)
- 22.67
- Revenue (TTM)
- $338.99M
- EBITDA (TTM)
- $147.40M
- Free Cashflow (TTM)
- $67.65M
Pricing
- 1D span
- $3.456$3.834
- 52W span
- $0.527$5.125
Analyst Ratings
The price target is $2.50 and the stock is covered by 4 analysts.
Buy
0
Hold
4
Sell
0
Information
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
- Employees
- 253
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- IRWD
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet